@article {Li2022.07.01.22277168, author = {Jing Li and Zeying Jiang and Wenyong Tan}, title = {Geometric changes to the central nervous system organs at risk during chemoradiotherapy for locally advanced nasopharyngeal carcinoma}, elocation-id = {2022.07.01.22277168}, year = {2022}, doi = {10.1101/2022.07.01.22277168}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Considerable geometric changes to the organs at risk (OARs) have been reported during treatment with chemotherapy and intensity modulated radiotherapy (chemo-IMRT) for locally advanced nasopharyngeal carcinoma (LA-NPC). This study aimed to quantify geometric changes to the central nervous system-related OARs (CNS-OARs), during chemo-IMRT for LA-NPC.Methods This prospective study included 20 patients with LA-NPC, treated with chemo-IMRT. Patients underwent a planning computed tomography (CT-plan) scan with intravenous contrast, followed by six weekly scans without contrast (CT-rep). For CNS-OARs, including the spinal cord, brainstem, optic chiasm and nerves, the globes of the eye, lens, and inner ears, their volume loss, the center of mass (COM) displacement, and spatial deformation was compared among weeks, respectively. The correlation between organ volume reduction and patients{\textquoteright} weight loss was estimated.Results The volume of the brainstem, spinal cord, and the globe of left-and right-side eye averagely decreased by 2.6{\textpm}2.3\% (95\% CI: 2.1\%, 3.1\%), 6.5{\textpm}4.8\% (5.6\%,7.4\%), 9.4{\textpm}6.9\% (8.1\%, 10.6\%) and 9.6{\textpm}7.8\% (8.2, 11.1\%) respectively. The volume reduction of the spinal cord and that of the brainstem were significantly correlated with patients{\textquoteright} weight loss. For all OARs, the COM displacement was within 3 mm, except for the lower level of the spinal cord. The DSC value of the spinal cord, brainstem, and the globes of the eye was of \>0.85 throughout treatment.Conclusions The volume and shape changes to the CNS-OARs during chemo-IMRT for NPC were quantifiable, which could be useful to refine radiation treatment protocols.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by National Natural Science Funding of China (81974462)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board for the Hubei Cancer Hospital (No. 2010V011, Aug. 19, 2010).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.}, URL = {https://www.medrxiv.org/content/early/2022/07/05/2022.07.01.22277168}, eprint = {https://www.medrxiv.org/content/early/2022/07/05/2022.07.01.22277168.full.pdf}, journal = {medRxiv} }